Elena Crisà

15PUBLICATIONS
67CO-AUTHORS
Molecular targetsGene and molecular therapyPacific Peoples and disabilityCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 27, 2026
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project.

|Sep 13, 2025
Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

Elena Crisà, Irene Dogliotti, Giuseppe Lia

|May 14, 2025
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.

Elena Crisà, Daniela Cilloni, Marta Riva

|Aug 05, 2024
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.

Elena Crisà, Elvira Mora, Ulrich Germing

|Jun 27, 2023
Strongyloides spp. and Cytomegalovirus Co-Infection in Patient Affected by Non-Hodgkin Lymphoma.

Tommaso Lupia, Elena Crisà, Alberto Gaviraghi

|Jun 09, 2023
Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS).

Esther Natalie Oliva, Marta Riva, Pasquale Niscola

Pageof 3

Frequent Collaborators

5 joint publications

Gianluca Gaidano

3 joint publications

Valeria Santini

2 joint publications

Novella Pugliese

2 joint publications

Guillermo Sanz